secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIxCrypto Holdings, Inc. (AIXC)
CIK:        0001460702
Form:       8-K
Filed at:   2025-06-24T23:59:59+00:00
Accession:  0001641172-25-016253
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Qualigen Therapeutics appoints Robert B. Lim as Audit Committee Chair
---------------------------------------------------------------------

- Robert B. Lim appointed Chair of Audit Committee effective June 20, 2025, replacing Graydon Bensler.
- Bensler remains on the Board and as a member of the Audit Committee.
- Lim is qualified as independent under Nasdaq rules and as an audit committee financial expert.
- No material interest or arrangement exists in connection with Lim's appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460702/000164117225016253/0001641172-25-016253-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460702/000164117225016253/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-016253

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer